Team SAHI
Markets recovered from intraday lows to end largely flat. Nifty stabilised as IT stocks offered support, while broader markets outperformed. Bank Nifty lagged and closed lower, weighed down by HDFC Bank.
Nifty tested its 50-DEMA near 26,080 and formed another indecisive candle. The 26,080–26,000 zone now acts as an important support band. Bank Nifty continues to hold above 59,800, with 59,500 as the next support. Sensex found support near its 50-DEMA around 84,600, while 85,250 remains the immediate resistance.
| Index | Support | Resistance |
|---|---|---|
| Nifty | 26,080 & 26,000 | 26,225 & 26,335 |
| Bank Nifty | 59,800 & 59,500 | 60,250 & 60,450 |
| Sensex | 84,600 & 84,400 | 85,250 & 85,550 |
| Gainers | Losers |
|---|---|
| TITAN +3.93% | CIPLA -4.11% |
| WIPRO +1.96% | MARUTI -2.79% |
| HCLTECH +1.94% | POWERGRID -1.66% |
Put writing at 26,000 (20.79L) and 26,100 (39.69L) is helping form a near-term base, while aggressive call writing at 26,200 (48.94L) signals strong supply. PCR-OI remains near 0.7.
Implication: Downside appears supported, but the upside is capped, pointing to a range-bound to mildly bearish setup unless call writing unwinds.
| Stock | % Move | What’s happening |
|---|---|---|
| TATAELXSI | +9.50% | IH&S breakout backed by strong long OI build-up |
| TATATECH | +5.29% | Clear double-bottom breakout with high volumes |
| PERSISTENT | +4.23% | Trading near upper consolidation band; breakout above 6,600 awaited |
| IEX | +4.11% | Breakout above 152, aligning with 50 EMA and volume support |
| CIPLA | -4.11% | Breakdown below 1,485 with strong selling volume |
Pattern: Symmetrical Triangle

Related
Recent
Fed's 2026 Outlook: Economic Resilience Meets Persistent Inflationary Pressures
Geopolitical Brinkmanship: Trump-Iran Tensions and the Indian Market Outlook
Zydus Lifesciences Disrupts Respiratory Care with India’s First Drug-Free Device 'Pepair' at ₹990
Infosys Pivots to 'AI-First' Era: New Framework Targets $300 Billion Market Opportunity
Zydus Lifesciences Disrupts Respiratory Care with India’s First Affordable Drug-Free Device ‘PepairTM’ at ₹990